{"id":"W1981193135","doi":"10.1016/j.ahj.2005.03.029","title":"The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale","year":2005,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Eptifibatide; Medicine; Acute coronary syndrome; Placebo; Randomized controlled trial; Internal medicine; Cardiology; ST segment; Clinical trial; ST elevation; Electrocardiography; Percutaneous coronary intervention; Myocardial infarction; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01100258,0.0004664255,0.002049513,0.0004355743,0.0004964984,0.0001438863,0.0002287393,0.0001366315,0.00004578789],"category_scores_gemma":[0.0006494921,0.0002476301,0.0004420616,0.0006675962,0.0006533096,0.0004377887,0.00006387465,0.0008179893,0.000007878808],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006285951,"about_ca_system_score_gemma":0.0007456882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006598581,"about_ca_topic_score_gemma":0.00004874481,"domain_scores_codex":[0.9880999,0.005508621,0.002896073,0.0005497578,0.002354385,0.0005912585],"domain_scores_gemma":[0.9922323,0.00447295,0.001868788,0.0005576505,0.000675437,0.0001929315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.936056,0.003130954,0.0419416,0.00000656654,0.002118556,0.00006495082,0.003527831,0.0007799264,0.0005102688,0.000002956039,0.0001082,0.01175225],"study_design_scores_gemma":[0.5413805,0.0561121,0.3992213,0.0001162472,0.0008176903,0.0001764899,0.0006458169,0.001300494,0.00005524086,0.00002113218,0.000005537245,0.0001474841],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9618134,0.0001254881,0.0009067484,0.00300506,0.0001813011,0.03390997,0.00003895163,0.00001426247,0.000004752244],"genre_scores_gemma":[0.9925815,0.0004059918,0.002146864,0.0003275972,0.0001802408,0.004169393,0.0000591275,0.00005065182,0.00007863576],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3946755,"threshold_uncertainty_score":0.9999976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04534038323094234,"score_gpt":0.3526609912596984,"score_spread":0.307320608028756,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}